US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NYLI Merger Arbitrage ETF

36.36

+0.10000.28%

Post-market: 36.360.00000.00%16:10 EDT

Volume:16.35K

Turnover:594.27K

Market Cap:252.70M

PE:- -

High:36.42

Open:36.32

Low:36.31

Close:36.26

52wk High:36.75

52wk Low:34.00

Shares:6.95M

Float Shares:6.95M

Volume Ratio:0.53

T/O Rate:0.24%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset

Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MNA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MNA\",,,,,undefined,":{"symbol":"MNA","market":"US","secType":"STK","nameCN":"NYLI Merger Arbitrage ETF","latestPrice":36.36,"timestamp":1776369600000,"preClose":36.26,"halted":0,"volume":16352,"hourTrading":{"tag":"盘后","latestPrice":36.36,"preClose":36.36,"latestTime":"16:10 EDT","volume":6,"amount":218.16,"timestamp":1776370204473,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.002757859900717083,"floatShares":6950000,"shares":6950000,"eps":0,"marketStatus":"Not Yet Opened","change":0.1,"latestTime":"04-16 16:00:00 EDT","open":36.32,"high":36.42,"low":36.31,"amount":594265.359872,"amplitude":0.003034,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":36.26,"sharesOutstanding":6950000,"nav":36.35391,"aum":252675903.08,"bidAskSpread":0.001024,"postHourTrading":{"tag":"盘后","latestPrice":36.36,"preClose":36.36,"latestTime":"16:10 EDT","volume":6,"amount":218.16,"timestamp":1776370204473,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.526025,"impliedVol":0.105,"impliedVolPercentile":0.4578},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MNA\",,,,,undefined,":{"symbol":"MNA","floatShares":6950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.526025,"shares":6950000,"dividePrice":0,"high":36.42,"amplitude":0.003034,"preClose":36.26,"low":36.31,"week52Low":34,"pbRate":"--","week52High":36.75,"institutionHeld":0,"latestPrice":36.36,"eps":0,"divideRate":0,"volume":16352,"delay":0,"ttmEps":0,"open":36.32,"prevYearClose":35.79,"prevWeekClose":36.2313,"prevMonthClose":36.35,"prevQuarterClose":36.35,"fiveDayClose":36.34,"twentyDayClose":36.01,"sixtyDayClose":35.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MNA\",params:#limit:5,,,undefined,":[{"date":"2023-12-28","symbol":"MNA","amount":0.37752,"announcedDate":"2023-12-27","type":"dividend","market":"US","newRecordDate":"2023-12-29","defaultRemindTime":1703773800000,"name":"IQ ARB Merger Arbitrage ETF","recordDate":"2024-01-05","payableDate":"2023-12-29","currency":"USD","dateTimestamp":1703739600000,"payDate":"2024-01-05"},{"market":"US","date":"2020-12-30","symbol":"MNA","amount":0.76599,"name":"IQ ARB Merger Arbitrage ETF","recordDate":"2021-01-07","payableDate":"2020-12-31","currency":"USD","type":"dividend","dateTimestamp":1609304400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MNA\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.06134,"currency":"USD"},{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-07","value":0.76599,"currency":"USD"},{"executeDate":"2023-12-28","recordDate":"2023-12-29","paymentDate":"2024-01-05","value":0.37752,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MNA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624305518","title":"Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset","url":"https://stock-news.laohu8.com/highlight/detail?id=2624305518","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624305518?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:30","pubTimestamp":1775043000,"startTime":"0","endTime":"0","summary":"Provides guidance on interpretation of Topline dataset and confirms focus on drug-driven efficacy in non-melanoma skin cancerPHILADELPHIA, April  01, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/01/3266511/0/en/Medicus-Pharma-Ltd-Clarifies-Positive-SkinJect-Phase-2-Dataset.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4023","BK4139","PD","MNA","CSR","BK4104","BK4215","LU1169589451.USD","BCC","LU1169590202.USD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622852318","title":"Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2622852318","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622852318?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:30","pubTimestamp":1774524600,"startTime":"0","endTime":"0","summary":"200g Cohort at Day 57 Dataset suggests majority of treated Lesions may Avoid Surgery as Company targets larger unmet medical need in Non-melanoma Skin CancerPHILADELPHIA, March  26, 2026 (GLOBE NEWSWI","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/26/3262893/0/en/Medicus-Pharma-Business-Update-Call-to-Highlight-80-Overall-Response-Rate-ORR-in-Phase-2-SkinJect-Study-and-Agentic-AI-enabled-Drug-Development-Plan.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","CHAT","BK4161","LU1169589451.USD","BK4567","MNA","BK4104","MDCX","PD","BCC","AGIX","CSR","BK4213","BK4215","PR","ORR","BK4023","LU1169590202.USD","CR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618662809","title":"Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset","url":"https://stock-news.laohu8.com/highlight/detail?id=2618662809","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618662809?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:30","pubTimestamp":1773055800,"startTime":"0","endTime":"0","summary":"The Company Reported 73% Clinical Clearance in the 200-g cohort at Day 57PHILADELPHIA, March  09, 2026  (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (\"Medicus\" or the \"Company\"), a biotech/l","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/09/3251726/0/en/Medicus-Pharma-Provides-Interpretation-of-Positive-Phase-2-SkinJect-Dataset.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","LU1674673428.USD","LU2236285917.USD","LU1496350171.SGD","LU0149725797.USD","BCC","LU0157215616.USD","LU1935042991.SGD","LU0314104364.USD","LU2456880835.USD","LU1066051498.USD","LU1935042215.USD","MDCX","LU0882574139.USD","LU1366192091.USD","LU2237443978.SGD","LU1778281490.HKD","LU0170899867.USD","LU1935042488.USD","LU2083900584.USD","MNA","LU1066053197.SGD","LU2237443382.USD","LU2420271590.USD","LU1066051225.USD","BK4104","LU1366333091.USD","LU0053666078.USD","LU1066051811.HKD","BK4567","LU1935043023.USD","BK4139","LU1935043536.SGD","LU2237443549.SGD","LU2417539215.USD","APC","LU1718418525.SGD","LU2237443622.USD","LU0786609619.USD","BK4214","LU0077335932.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617979542","title":"Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2617979542","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617979542?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:30","pubTimestamp":1772713800,"startTime":"0","endTime":"0","summary":"The Company is expected to finalize the Clinical Study Report (CSR) in Q2 2026 to support planned end of Phase 2 (EOP2) meeting with the FDAPHILADELPHIA, March  05, 2026  (GLOBE NEWSWIRE) -- Medicus P","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/05/3250045/0/en/Medicus-Pharma-Reports-Positive-Phase-2-SKNJCT-003-Topline-Data-Observing-73-Clinical-Clearance-and-40-Histological-Clearance-CR-at-Day-57-in-200%CE%BCg-Cohort.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR","LU1366333091.USD","LU2456880835.USD","BK4161","BK4139","LU1935043536.SGD","MDCX","LU0077335932.USD","LU2417539215.USD","BCC","LU1718418525.SGD","LU0053666078.USD","LU1935042488.USD","APC","LU1496350171.SGD","BK4567","LU1935042991.SGD","LU0882574139.USD","LU2237443382.USD","LU1935043023.USD","LU0170899867.USD","LU1778281490.HKD","LU0314104364.USD","CSR","BK4104","LU1066053197.SGD","LU1674673428.USD","LU1674673691.USD","BK4215","LU2083900584.USD","LU1066051225.USD","LU0157215616.USD","LU2237443549.SGD","BK4214","LU2420271590.USD","LU0149725797.USD","LU1066051811.HKD","LU2236285917.USD","LU2237443622.USD","LU1366192091.USD","LU1066051498.USD","LU0786609619.USD","LU2237443978.SGD","LU1935042215.USD","MNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MNA\",params:#limit:6,delay:false,,,undefined,":[]}}